Nevalainen T J, Kortesuo P T, Rintala E, Märki F
Department of Pathology, University of Turku, Finland.
Clin Chem. 1992 Sep;38(9):1824-9.
Time-resolved fluoroimmunoassay was developed for the detection of synovial-type phospholipase A2 (s-PLA2) in human serum. This solid-phase, sandwich assay uses a polyclonal rabbit antibody raised against synovial-type group II PLA2 produced in Escherichia coli. No cross-reactions were detected between s-PLA2 and PLA2 from human or porcine pancreas, human ascitic fluid, or bee or cobra venom. In healthy individuals, the average concentration of s-PLA2 is 3.7 micrograms/L, with a 95% reference interval from 1.3 to 10.8 micrograms/L. We investigated pancreatic PLA2, which is a group I PLA2, and synovial-type group II PLA2 in sera of patients with hematological malignancies and septic fever. The concentration of s-PLA2 was increased in patient sera and correlated significantly with the catalytic activity of PLA2 and the concentration of C-reactive protein. No correlation with the concentration of pancreatic PLA2 was found. The results suggest that the increased catalytic activity of PLA2 in sera of patients with septic fever results from synovial-type group II PLA2.
时间分辨荧光免疫分析法被开发用于检测人血清中的滑膜型磷脂酶A2(s-PLA2)。这种固相夹心分析法使用针对在大肠杆菌中产生的滑膜型II组磷脂酶A2制备的兔多克隆抗体。未检测到s-PLA2与人或猪胰腺中的磷脂酶A2、人腹水、蜜蜂或眼镜蛇毒液之间的交叉反应。在健康个体中,s-PLA2的平均浓度为3.7微克/升,95%参考区间为1.3至10.8微克/升。我们研究了血液系统恶性肿瘤和败血症发热患者血清中的I组磷脂酶A2即胰腺磷脂酶A2和滑膜型II组磷脂酶A2。患者血清中s-PLA2的浓度升高,且与磷脂酶A2的催化活性和C反应蛋白的浓度显著相关。未发现与胰腺磷脂酶A2的浓度有相关性。结果表明,败血症发热患者血清中磷脂酶A2催化活性的增加是由滑膜型II组磷脂酶A2引起的。